About
Overview
Management team
Board of directors
Scientific advisory board
Innovation
Overview
Pipeline
Technology
Clinical trials
Overview
LUCE-1
STELLA
For patients
Overview
Usher 1B
Stargardt
News
Careers
Overview
Recruitment companies
Contact
EN
English
Italiano
Search
News
News
Filter by:
All categories
All categories
Press Release
Publication
All disease areas
All disease areas
Stargardt
Usher 1B
Other
By year:
All years
All years
2024
2023
2022
2021
2019
2014
Reset
08.11.2023
Press Release
Other
AAVantgarde Appoints Dr. Peter K. Kaiser to the Board of Directors
30.10.2023
Press Release
Other
AAVantgarde Appoints Michael Heffernan as Chairman of its Board of Directors
12.09.2023
Press Release
Other
AAVantgarde Appoints Dr. Doug Kerr to the Board of Directors
06.06.2023
Press Release
Other
AAVantgarde Closes €61 Million Series A Financing to Advance Two Therapeutic Programs into the Clinic
09.03.2023
Publication
Usher 1B
Efficacy, pharmacokinetics, and safety in the mouse and primate retina of dual AAV vectors for Usher syndrome type 1B